ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CAT Catco Reinsurance Opportunities Fund Limited

24.00
0.00 (0.00%)
16 Aug 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Catco Reinsurance Opportunities Fund Limited LSE:CAT London Ordinary Share BMG1961Q3242 ORD USD0.00013716 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 24.00 13.00 35.00 24.00 24.00 24.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt 6.33M 5.44M 3.6440 6.59 35.84M

Cambridge Antibody - Director Shareholding

02/06/2000 12:19pm

UK Regulatory


RNS Number:6007L
Cambridge Antibody Tech Group PLC
2 June 2000


Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
Cambridge Antibody Technology

2   Name of director:
John Aston

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
as in 2

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
As in 2

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):
As in 2

6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
Allocation of pro-rata entitlement pursuant to open offer to shareholders

7   Number of shares/amount of stock acquired:
362

8   Percentage of issued class:
0.0011%

9   Number of shares/amount of stock disposed:


10  Percentage of issued class:


11  Class of security:
10p ordinary shares

12  Price per share:
1850p

13  Date of transaction:
10 April 2000

14  Date company informed:
10 April 2000

15  Total holding following this notification:
2,489

16  Total percentage holding of issued class following this notification:
0.0073%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:


18  Period during which or date on which exercisable:


19  Total amount paid (if any) for grant of the option:


20  Description of shares or debentures involved: class, number:


21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:


22  Total number of shares or debentures over which options held following
this notification:


23  Contact name for queries:
Diane Mellett

24  Contact telephone number:
01763 263 233

25  Name of company official responsible for making notification:
Diane Mellett




Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
Cambridge Antibody Technology

2   Name of director:
Peter Garland

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
as in 2

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
as in 2

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):
as in 2

6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
Allocation of pro-rata entitlement pursuant to open offer to shareholders

7   Number of shares/amount of stock acquired:
270

8   Percentage of issued class:
0.0008%

9   Number of shares/amount of stock disposed:


10  Percentage of issued class:


11  Class of security:
10p ordinary shares

12  Price per share:
1850p

13  Date of transaction:
10 April 2000

14  Date company informed:
10 April 2000

15  Total holding following this notification:
82,006

16  Total percentage holding of issued class following this notification:
0.24%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:


18  Period during which or date on which exercisable:


19  Total amount paid (if any) for grant of the option:


20  Description of shares or debentures involved: class, number:


21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:


22  Total number of shares or debentures over which options held following
this notification:


23  Contact name for queries:
Diane Mellett

24  Contact telephone number:
01763 263233

25  Name of company official responsible for making notification:
Diane Mellett




Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
Cambridge Antibody Technology

2   Name of director:
Uwe Bicker

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
as in 2 

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
as in 2 

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):
As in 2

6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
Allocation of pro-rata entitlement pursuant to open offer to shareholders

7   Number of shares/amount of stock acquired:
246

8   Percentage of issued class:
0.0007%

9   Number of shares/amount of stock disposed:


10  Percentage of issued class:


11  Class of security:
10p ordinary shares

12  Price per share:
1850p

13  Date of transaction:
10 April 2000

14  Date company informed:
10 April 2000

15  Total holding following this notification:
1,988

16  Total percentage holding of issued class following this notification:
0.0058%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:


18  Period during which or date on which exercisable:


19  Total amount paid (if any) for grant of the option:


20  Description of shares or debentures involved: class, number:


21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:


22  Total number of shares or debentures over which options held following
this notification:


23  Contact name for queries:
Diane Mellett

24  Contact telephone number:
01763 263233

25  Name of company official responsible for making notification:
Diane Mellett




Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
Cambridge Antibody Technology

2   Name of director:
Paul Nicholson

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
as in 2

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
as in 2

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):
As in 2

6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
Allocation of pro-rata entitlement pursuant to open offer to shareholders

7   Number of shares/amount of stock acquired:
529

8   Percentage of issued class:
0.0015%

9   Number of shares/amount of stock disposed:


10  Percentage of issued class:


11  Class of security:
10p ordinary shares

12  Price per share:
1850p

13  Date of transaction:
10 April 2000

14  Date company informed:
10 April 2000

15  Total holding following this notification:
4,271

16  Total percentage holding of issued class following this notification:
0.012%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:


18  Period during which or date on which exercisable:


19  Total amount paid (if any) for grant of the option:


20  Description of shares or debentures involved: class, number:


21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:


22  Total number of shares or debentures over which options held following
this notification:


23  Contact name for queries:
Diane Mellett

24  Contact telephone number:
01763 263233

25  Name of company official responsible for making notification:
Diane Mellett




Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
Cambridge Antibody Technology

2   Name of director:
John Stocker

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
As in 2 above

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
As in 2 above

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):
As in 2

6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
Allocation of pro-rata entitlement pursuant to open offer to shareholders

7   Number of shares/amount of stock acquired:
387

8   Percentage of issued class:
0.0011%

9   Number of shares/amount of stock disposed:


10  Percentage of issued class:


11  Class of security:
10p ordinary shares

12  Price per share:
1850p

13  Date of transaction:
10 April 2000

14  Date company informed:
10 April 2000

15  Total holding following this notification:
3,129

16  Total percentage holding of issued class following this notification:
0.0091%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:


18  Period during which or date on which exercisable:


19  Total amount paid (if any) for grant of the option:


20  Description of shares or debentures involved: class, number:


21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:


22  Total number of shares or debentures over which options held following
this notification:


23  Contact name for queries:
Diane Mellett

24  Contact telephone number:
01763 263233

25  Name of company official responsible for making notification:
Diane Mellett


END
RDSEAFKAEEDEEFE


1 Year Catco Reinsurance Opport... Chart

1 Year Catco Reinsurance Opport... Chart

1 Month Catco Reinsurance Opport... Chart

1 Month Catco Reinsurance Opport... Chart

Your Recent History

Delayed Upgrade Clock